Search Results - "Pryzdial, Ed L.G"

Dengue Virus Persists in Stored Platelets and Red Blood Cells by Sutherland, Michael R, Simon, Ayo Y, Serrano, Katherine, Schubert, Peter, Acker, Jason, Pryzdial, Ed L.G

Get full text

Tissue Factor On The Herpes Simplex Virus Type 1 Surface Enhances Infection In Vivo by Sutherland, Michael R, Simon, Ayo Y, Shanina, Iryna, Horwitz, Marc S, Ruf, Wolfram, Pryzdial, Ed L.G.

“…Tissue factor (TF) is a multifunctional transmembrane receptor. As the pivotal initiator of the coagulant response to vascular damage, it accelerates factor…”
Get full text

Covalent Stabilization Of Coagulation Factor Xa Enhances Its Fibrinolytic Function In Vitro and In Vivo: A Novel Cofactor-Based Thrombolytic Agent by Pryzdial, Ed L.G., Talbot, Kimberley, Meixner, Scott C., Eltringham-Smith, Louise J., Sheffield, William P

“…The key “clot-busting” enzyme, tissue plasminogen activator (tPA), functions to activate plasminogen (Pg) to plasmin, which directly cleaves and solubilizes…”
Get full text

Persistence Of Dengue Virus In Stored Platelets and Red Blood Cells by Sutherland, Michael R, Simon, Ayo Y, Serrano, Katherine, Schubert, Peter, Acker, Jason, Pryzdial, Ed L.G.

“…Dengue virus (DENV), a single stranded RNA member of the Flavivirus family, is responsible for morbidity and mortality, causes ∼50 million infections annually,…”
Get full text

Herpesviruses Enhance Fibrinogen Clot Lysis by Gershom, Edwin S, Hoek, Amanda Vanden, Sutherland, Michael R, Pryzdial, Ed L.G.

“…Abstract 1153 Members of the Herpesvirus family have been implicated in vascular disease. To explain the correlation on a molecular basis we have shown that…”
Get full text

Identification of a Novel Coagulation Factor X Compound Heterozygous Mutation Associated with Differential Initiating Clotting Pathway Function by Hoek, Amanda L Vanden, Talbot, Kimberley, Carter, Isis, Vickars, Linda, Carter, Cedric John, MacGillivray, Ross T.A., Pryzdial, Ed L.G.

“…Abstract 1129 Factor × (FX) deficiency is a rare form of haemophilia characterized by a decrease in circulating FX antigen and/or activity levels, which can…”
Get full text

Identification and Cloning of Novel Mutations In a Compound Heterozygous Factor V Deficient Patient by Talbot, Kimberley, Song, Jina, Eghdami, Lily, Tamura-Wells, Jessica, Hewitt, Jeff, Vickars, Linda, Carter, Cedric John, MacGillivray, Ross T.A., Pryzdial, Ed L.G.

“…Abstract 2210 Congenital factor V (FV) deficiency is a rare clotting disorder associated with mild to severe hemorrhagic symptoms and a prevalence of…”
Get full text

Novel Compound Heterozygous Factor V Deficiency with Severe Clinical Phenotype by Talbot, Kimberley, Song, Jina, Eghdami, Lily, Hewitt, Jeff, Carter, Cedric J., MacGillivray, Ross T.A., Pryzdial, Ed L.G.

“…Abstract 3490 Poster Board III-427 Congenital factor V (FV) deficiency is a rare clotting disorder associated with mild to severe hemorrhagic symptoms and a…”
Get full text

Plasmin-Mediated Coagulation Factor Xa Derivative, Xa33/13, Enhances Plasminogen Activation and Fibrin Clot Lysis by Pryzdial, Ed L.G., Talbot, Kimberley, Meixner, Scott C.

“…Previous reports showed that coagulation factor Xa (FXa) treated with the fibrinolysis protease, plasmin, loses procoagulant activity and can accelerate tissue…”
Get full text